Sabra Healthcare REIT, Inc. $SBRA is Engineers Gate Manager LP’s 4th Largest Position

Engineers Gate Manager LP lowered its position in Sabra Healthcare REIT, Inc. (NASDAQ:SBRA) by 25.0% in the fourth quarter, Holdings Channel.com reports. The institutional investor owned 4,544,219 shares of the real estate investment trust’s stock after selling 1,513,777 shares during the period. Sabra Healthcare REIT comprises approximately 1.0% of Engineers Gate Manager LP’s holdings, making the stock its 4th largest position. Engineers Gate Manager LP’s holdings in Sabra Healthcare REIT were worth $86,068,000 as of its most recent filing with the Securities and Exchange Commission.

A number of other institutional investors and hedge funds also recently added to or reduced their stakes in the company. Vanguard Group Inc. lifted its stake in Sabra Healthcare REIT by 1.4% in the fourth quarter. Vanguard Group Inc. now owns 35,430,016 shares of the real estate investment trust’s stock valued at $671,045,000 after buying an additional 481,231 shares during the last quarter. Principal Financial Group Inc. lifted its stake in Sabra Healthcare REIT by 21.6% in the fourth quarter. Principal Financial Group Inc. now owns 24,953,351 shares of the real estate investment trust’s stock valued at $472,617,000 after buying an additional 4,431,897 shares during the last quarter. Nuveen LLC lifted its stake in Sabra Healthcare REIT by 28.6% in the fourth quarter. Nuveen LLC now owns 7,303,254 shares of the real estate investment trust’s stock valued at $138,324,000 after buying an additional 1,625,072 shares during the last quarter. Geode Capital Management LLC lifted its stake in Sabra Healthcare REIT by 2.9% in the fourth quarter. Geode Capital Management LLC now owns 7,018,556 shares of the real estate investment trust’s stock valued at $132,949,000 after buying an additional 198,118 shares during the last quarter. Finally, Bank of America Corp DE lifted its stake in Sabra Healthcare REIT by 9.4% in the third quarter. Bank of America Corp DE now owns 5,224,116 shares of the real estate investment trust’s stock valued at $97,378,000 after buying an additional 447,528 shares during the last quarter. Hedge funds and other institutional investors own 99.40% of the company’s stock.

Analyst Upgrades and Downgrades

Several equities analysts recently issued reports on the company. Truist Financial boosted their price target on Sabra Healthcare REIT from $21.00 to $22.00 and gave the company a “hold” rating in a research report on Friday, March 13th. UBS Group boosted their price target on Sabra Healthcare REIT from $21.00 to $22.00 and gave the company a “neutral” rating in a research report on Wednesday, May 13th. Wall Street Zen upgraded Sabra Healthcare REIT from a “sell” rating to a “hold” rating in a research report on Monday, May 18th. Raymond James Financial started coverage on Sabra Healthcare REIT in a research report on Wednesday. They issued an “underperform” rating on the stock. Finally, Citizens Jmp boosted their price target on Sabra Healthcare REIT from $22.00 to $23.00 and gave the company a “market outperform” rating in a research report on Wednesday, February 18th. Five investment analysts have rated the stock with a Buy rating, five have given a Hold rating and one has assigned a Sell rating to the stock. Based on data from MarketBeat, the stock has a consensus rating of “Hold” and a consensus target price of $22.40.

Sabra Healthcare REIT Stock Down 2.7%

Shares of NASDAQ:SBRA opened at $18.05 on Thursday. The company has a market cap of $4.55 billion, a price-to-earnings ratio of 28.65, a PEG ratio of 1.38 and a beta of 0.64. The firm’s 50-day simple moving average is $19.98 and its 200-day simple moving average is $19.67. The company has a quick ratio of 4.72, a current ratio of 4.72 and a debt-to-equity ratio of 0.96. Sabra Healthcare REIT, Inc. has a fifty-two week low of $17.17 and a fifty-two week high of $21.28.

Sabra Healthcare REIT (NASDAQ:SBRA) last issued its earnings results on Wednesday, April 29th. The real estate investment trust reported $0.16 earnings per share for the quarter, meeting the consensus estimate of $0.16. The business had revenue of $211.74 million for the quarter, compared to the consensus estimate of $209.20 million. Sabra Healthcare REIT had a net margin of 19.22% and a return on equity of 5.60%. The business’s quarterly revenue was up 20.9% compared to the same quarter last year. During the same quarter in the previous year, the firm earned $0.37 earnings per share. Sabra Healthcare REIT has set its FY 2026 guidance at 1.550-1.590 EPS. As a group, equities research analysts predict that Sabra Healthcare REIT, Inc. will post 1.51 earnings per share for the current year.

Sabra Healthcare REIT Announces Dividend

The company also recently announced a quarterly dividend, which was paid on Friday, May 29th. Stockholders of record on Friday, May 15th were issued a $0.30 dividend. The ex-dividend date of this dividend was Friday, May 15th. This represents a $1.20 annualized dividend and a dividend yield of 6.6%. Sabra Healthcare REIT’s payout ratio is presently 190.48%.

Sabra Healthcare REIT Profile

Sabra Healthcare REIT, Inc (NASDAQ: SBRA) is a real estate investment trust that acquires, owns and operates net‐lease healthcare properties. Its diversified portfolio spans senior housing communities, skilled nursing and rehabilitation centers, outpatient medical facilities, medical office buildings, hospitals and life science properties. Sabra structures long‐term, triple‐net lease agreements with healthcare operators, providing stable rental income streams while allowing tenants to focus on patient care and operational excellence.

Serving a broad spectrum of care segments, Sabra’s tenants include both regional and national providers of assisted living, independent living, memory care, post‐acute rehabilitation and research and development laboratories.